kabutan

PhoenixBio, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Turns to Profit

Fri Feb 13, 2026 3:40 pm JST Earnings

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Earnings Report

PhoenixBio Co.,Ltd. <6190> [TSE Growth] announced its financial results after the market closed on February 13th (15:40). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending March 2026 (April to December) turned into a profit of 98 million yen (compared to a loss of 146 million yen in the same period last year). Progress toward the full-year plan of 116 million yen was 84.5%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a profit of 18 million yen (compared to a loss of 9 million yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit/loss turned to a profit of 82 million yen (compared to a loss of 23 million yen in the same period last year). The operating profit/loss margin drastically improved from -15.5% in the same period last year to 14.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 1,328 30 32 14 3.9 74.4 Feb 14, 2024 J-GAAP
Apr - Dec, 2024 1,143 -153 -146 -150 -37.3 ー Feb 14, 2025 J-GAAP
Apr - Dec, 2025 1,200 68 98 93 22.9 84.5 Feb 13, 2026 J-GAAP
YoY +5.0% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 753 -44 -32 -324 -80.3 0 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 884 104 100 98 24.1 0 Nov 14, 2025 J-GAAP
YoY +17.4% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 1,715 11 43 26 7.0 0 May 15, 2024 J-GAAP
Mar, 2025 1,541 -142 -155 -448 -111.0 0 May 15, 2025 J-GAAP
Mar, 2026 Guidance 1,640 109 116 110 27.0 0 Nov 14, 2025 J-GAAP
YoY +6.4% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 355 -55 -23 -26 -6.5 -15.5 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 398 11 -9 -298 -73.8 2.8 May 15, 2025 J-GAAP
Apr - Jun, 2025 400 23 20 19 4.7 5.8 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 356 -18 -4 -7 -1.8 -5.1 Nov 14, 2025 J-GAAP
Oct - Dec, 2025 444 63 82 81 20.0 14.2 Feb 13, 2026 J-GAAP
YoY +25.1% － － － －

Related Articles